Skip to main content
. 2022 May 19;18:187. doi: 10.1186/s12917-022-03289-2

Table 3.

Total VFAs (mg/100 ml) and individual VFAs expressed as a percentage (%) of total VFAs in the different intestinal compartments of the equine digestive tract according to the dietary treatment received (HS vs. HF)

Intestinal compartments VFAs HS HF p-value
Diet Sex Diet*Sex
SI Total VFAs 182.82 (130.20–235.04) 176.81 (142.89–238.49) 0.99 0.52 0.90
Succinic 11.09 (3.00–14.29) 3.86 (0–16.87) 0.29 0.47 0.80
Lactic 5.23 (3.60–7.83) 5.62 (2.96–26.27) 0.76 0.19 0.46
Formic 0 (0–1.04) 0 (0–2.59) 0.92 0.05 0.92
Acetic 55.37 (4.15) 51.32 (5.44) 0.63 0.54 0.65
Propionic 0 (0–0) 0 (0–0) 0.74 0.26 0.74
Iso-butyric 24.84 (11.05–32.57) 16.41 (11.63–24.66) 0.55 0.02*a 0.50
Butyric 0 (0–0) 0 (0–0) 1.00 1.00 1.00
Iso-valeric 0 (0–0) 0 (0–0.80) 0.38 0.38 0.38
Valeric 0 (0–0) 0 (0–0.88) 0.59 0.64 0.75
CAE Total VFAs 510.72 (261.05–771.56) 389.17 (290.76–462.55) 0.57 0.95 0.30
Succinic 0 (0–0) 0 (0–0) 0.84 0.36 0.84
Lactic 5.90 (2.43–6.84) 3.57 (2.79–6.65) 0.55 0.74 0.66
Formic 0.50 (0.22–0.91) 0 (0–0.99) 0.10 0.01*b 0.97
Acetic 20.19 (14.00) 30.16 (1.07) < 0.01* 0.88 0.53
Propionic 4.19 (3.69–5.31) 9.05 (6.91–10.72) < 0.01* 0.32 0.79
Iso-butyric 45.09 (43.05–52.16) 51.84 (47.31–56.48) < 0.01* 0.11 0.90
Butyric 2.01 (1.66–2.18) 3.79 (2.85–4.23) < 0.01* 0.31 0.54
Iso-valeric 0 (0–0) 0 (0–0) 0.38 0.38 0.38
Valeric 19.26 (15.00–27.36) 0 (0–0) < 0.01* 0.64 0.64
SF Total VFAs 838.11 (622.74–1054.03) 436.14 (381.38–489.42) < 0.01* 0.87 0.09
Succinic 0 (0–1.21) 0.50 (0.31–0.95) 0.19 0.35 0.79
Lactic 5.70 (0.10–6.66) 6.73 (4.88–12.33) 0.06 0.62 0.36
Formic 0.32 (0.27–1.11) 0.65 (0–1.48) 0.74 0.58 0.47
Acetic 17.71 (1.51) 33.42 (1.73) < 0.01* 0.29 0.08
Propionic 3.80 (2.55–4.44) 8.67 (7.01–9.74) < 0.01* 0.40 0.63
Iso-butyric 39.29 (37.77–42.78) 43.90 (36.91–49.68) 0.31 0.34 0.95
Butyric 2.72 (2.54–3.26) 6.19 (5.35–7.29) < 0.01* 0.52 0.29
Iso-valeric 0 (0–0.14) 0 (0–0) 0.51 0.37 0.69
Valeric 30.74 (26.19–36.94) 0 (0–0) < 0.01* 0.06 0.06
PF Total VFAs 897.97 (804.56–1121.135) 303.72 (235.53–342.82) < 0.01* 0.30 0.50
Succinic 0 (0–0.68) 0.47 (0–1.42) 0.50 0.52 0.17
Lactic 1.94 (0.23–3.92) 1.93 (0.90–2.44) 0.92 0.96 0.21
Formic 0 (0–0.65) 0.23 (0–1.19) 0.51 0.68 0.25
Acetic 13.93 (1.58) 36.61 (0.75) < 0.01* 0.27 0.49
Propionic 2.48 (2.23–3.64) 9.60 (8.08–10.82) < 0.01* 0.22 0.75
Iso-butyric 36.44 (32.23–42.31) 47.17 (43.81–48.63) < 0.01* 0.28 0.04*c
Butyric 2.04 (1.31–2.30) 4.10 (2.54–5.45) < 0.01* 0.13 0.72
Iso-valeric 0 (0–0.20) 0 (0–0.47) 0.88 0.94 0.99
Valeric 43.34 (36.43–43.32) 0 (0–0) < 0.01* 0.33 0.33
RDC Total VFAs 835.54 (672.89–1090.51) 284.62 (202.24–340.58) < 0.01* 0.58 0.41
Succinic 0.10 (0–0.56) 0 (0–0.60) 0.46 0.10 0.88
Lactic 0.25 (0–3.29) 3.03 (1.40–3.80) 0.07 0.58 0.60
Formic 0 (0–0.19) 0 (0–0.21) 0.76 0.63 0.25
Acetic 15.93 (1.86) 36.31 (2.29) < 0.01* 0.16 0.72
Propionic 3.40 (2.73–3.84) 8.92 (6.84–9.46) < 0.01* 0.40 0.52
Iso-butyric 39.10 (25.67–41.05) 46.62 (41.49–56.17) < 0.01* 0.14 < 0.01*d
Butyric 1.78 (1.44–4.16) 3.20 (2.35–4.16) < 0.01* 0.56 0.98
Iso-valeric 0.18 (0–0.59) 0 (0–0) 0.06 0.13 0.43
Valeric 39.25 (36.39–52.21) 0 (0–0) < 0.01* 0.33 0.33
RE Total VFAs 605.76 (585.70–916.29) 195.39 (134.52–295.35) < 0.01* 0.21 0.83
Succinic 0 (0–1.02) 0 (0–0) 0.08 0.58 0.58
Lactic 3.04 (0.34–5.89) 3.32 (2.14–4.13) 0.61 0.08 0.28
Formic 0 (0–0.23) 0 (0–1.06) 0.70 0.08 0.70
Acetic 13.13 (1.37) 28.82 (1.69) < 0.01* 0.05 0.71
Propionic 2.08 (1.93–3.72) 6.61 (5.89–8.80) < 0.01* 0.49 0.31
Iso-butyric 37.12 (30.67–52.77) 62.16 (53.42–64.11) < 0.01* 0.29 0.03*e
Butyric 1.45 (0.79–2.11) 2.00 (0.93–2.60) 0.92 0.17 0.95
Iso-valeric 0 (0–0) 0 (0–0) 0.26 0.26 0.26
Valeric 44.59 (19.98–51.79) 0 (0–0) < 0.01* 0.11 0.11

Data not normally distributed are expressed as medians (25th–75th percentiles); data normally distributed are expressed as means (SEM)

HS high starch, HF high fibre, SI small intestine, CAE apex of the caecum, SF ventral diaphragmatic flexure of the colon, PF pelvic flexure, RDC right dorsal colon, RE rectum. *statistical significance p < 0.05

*amales 30.50 (19.19–38.45); females 15.68 (7.97–22.90)

*bfemales 0.71 (0.12–1.33); males 0 (0–0.45)

*cmales HF 47.99 (46.75–50.55)A; females HF 46.44 (40.00–47.66)A; females HS 40.78 (34.74–50.79)AB; males HS 32.90 (28.32–36.35)B. A,B p < 0.05

*dmales HF 52.79 (47.17–60.11)A; females HF 43.19 (38.83–55.10)A; females HS 40.92 (35.16–48.41)A; males HS 25.67 (18.70–31.67)B. A,B p < 0.05

*emales HF 63.42 (62.30–64.41)A; females HF 57.33 (50.34–60.02)A; females HS 37.68 (36.17–66.13)AB; males HS 30.67 (23.87–37.92)B. A,B p < 0.05